Sea Crest Wealth Management, LLC Repligen Corp Transaction History

Sea Crest Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$140.68 - $188.02 $14,490 - $19,366	103 New	103 $17,000
Q2 2019 Jul 19, 2019	SELL	$54.2 - $85.95 $8,130 - $12,892	-150 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$49.45 - $62.8 $3,708 - $4,710	75 Added 100.0%	150 $9,000
Q4 2018 Feb 13, 2019	BUY	$48.26 - $68.88 $3,619 - $5,166	75 New	75 $4,000

495

57.6M

75.6K

521K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.07B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.